tiprankstipranks
Spero Therapeutics Announces Chief Legal Officer’s Resignation
Company Announcements

Spero Therapeutics Announces Chief Legal Officer’s Resignation

Spero Therapeutics Inc (SPRO) has released an update to notify the public and investors about its officers.

Don't Miss our Black Friday Offers:

Tamara Joseph is resigning as Chief Legal Officer and Corporate Secretary of Spero Therapeutics to explore new opportunities, effective March 6, 2024. She will receive severance pay and a pro-rated bonus totaling approximately $390,565.73, with ongoing benefits including consulting at $395 per hour for nine months and continued vesting of her stock options and RSUs. Spero’s CEO, Sath Shukla, expressed gratitude for her contributions and best wishes for her future. Details of her separation and consulting agreements will be disclosed in the company’s annual report.

For further insights into SPRO corporate activity, check out TipRanks’ Insiders Trading Activity page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TheFlySpero Therapeutics downgraded to Hold from Buy at TD Cowen
TipRanks Auto-Generated NewsdeskSpero Therapeutics: Strategic Shift and Earnings Update
TheFlySpero Therapeutics reports Q3 EPS (32c), consensus (36c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App